| 31-Jan-2021 | |||||||
| GLOBAL INVESTING MODEL PORTFOLIOS | |||||||
| Yield Portfolio | |||||||
| For investors seeking current income | Initial | Current | Yield/ | ||||
| purchase date | name | ticker | Price | price | Gain | YTM | |
| 03-Sep-2000 | SchlumbergerLtd &% | SLB | 23.75 | 22.21 | -6.47% | 1.50% | BUY |
| 04-May-2004 | Vodafone 6.25% of '32% | 92857WAB6 | 966.30 | 1,358.00 | 40.54% | 5.72% | BUY |
| 31-Jul-2007 | Bank of Nova Scotia | BNS | 46.27 | 53.71 | 16.08% | 5.10% | BUY |
| 10-Oct-2007 | BCE & | BCE | 30.27 | 43.89 | 45.00% | 7.00% | BUY |
| 29-Jan-2021 | BCE & | 42.52 | 42.52 | 0.00% | 7.00% | ||
| 30-Dec-1899 | SampoOy A | SAXPY.PK | 16.36 | 20.96 | 28.16% | 4.57% | BUY |
| Nordea Bank spinoff | NRDBY | 6.00 | 8.06 | 34.33% | 9.97% | SAXPY spinoff | |
| 08-Aug-2019 | Banco Latino& | BLX | 16.35 | 15.24 | -6.79% | 13.40% | HOLD |
| 25-May-2011 | Santander Group | SAN | 4.59 | 2.93 | -36.17% | 3.00% | BUY |
| 27-May-2011 | GlaxoSmithKline | GSK | 44.14 | 37.25 | -7.80% | 6.00% | BUY |
| 13-Jul-2012 | Nutrien | NTR | 39.13 | 49.17 | 25.67% | 6.50% | BUY |
| 10-Jul-2013 | Vodafone plc ord | VOD | 14.57 | 17.15 | 22.22% | 9.72% | BUY |
| 04-Dec-2014 | BP plc & | BP | 36.97 | 22.22 | -39.90% | 14.38% | ½ sold |
| 04-Jan-2017 | Algonquin | AQN | 8.43 | 16.62 | 97.15% | 5.01% | BUY |
| 10-Aug-2017 | E.On SE | EONGY | 10.49 | 10.65 | 1.53% | 4.16% | BUY |
| 10-Aug-2017 | Santander pr B | SAN+B | 23.45 | 25 | 6.63% | 4.50% | Called |
| 25-Mar-2018 | Teva 0.25% of 2026 | 88263VAE9 | 884.5 | 988.2 | 11.72% | 3.60% | BUY |
| 04-Jan-2019 | HoeghLNG PartnersLP8.75cum pref | HMLP.PR.A | 24.72 | 25 | 1.13% | 17.50% | BUY |
| 10-Jul-2019 | Royal Dutch Shell | RDS-B | 65.69 | 34.89 | -46.89% | 15.69% | BEST BUY |
| 08-Aug-2019 | TEVA 6.15% of 2036 | 88163VAD1 | 792.17 | 1098.5 | 38.67% | 10.04% | BUY |
| 08-Jun-2020 | Astra-Zeneca plc | AZN | 52.62 | 50.6 | -3.84% | 2.66% | NEW |
| 14-Apr-2020 | Sumitomo Mitsui FG | SMFG | 5.23 | 6.21 | 18.85% | 0.00% | NEW |
| 07-Sep-2020 | Mitsubishi Corp | MSBHF | 20.45 | 25.45 | 24.45% | 0.00% | NEW |
| 18-Dec-2020 | Atlantica Yield | AY | 40 | 41.35 | 3.38% | 3.64% | BEST BUY |
| average gain, yield | 11.15% | 6.69% | |||||
| (%) = suitable for tax-deferred acct | &=avrgd down | ###=half sold | |||||
| purchase date | Buy & Hold Portfolio | ticker | Initial | Current | Gain | Yield | |
| For growth and income | Price | Price | |||||
| 06-Apr-1998 | Tomra | TMRAY | 19.80 | 47.40 | 69.70% | 1.11% | BUY, half sold |
| 11-Jan-2006 | Naspers | NPSNY | 1.65 | 45.00 | 1311.16% | 0.14% | half sold |
| Prosus spinoff | PROSY | 8.67 | 23.44 | 85.18% | 0.00% | ||
| 31-Oct-2011 | CAE | CAE | 9.54 | 22.55 | 136.37% | 1.40% | BUY |
| 18-Jan-2013 | Computer Modelling ### | CMDXF | 8.45 | 4.42 | -23.85% | 6.64% | ½ sold |
| 18-Nov-2013 | Cameco CP | CCJ | 13.37 | 12.42 | -7.11% | 3.30% | BUY |
| 17-Sep-2014 | NovoNordisk | NVO & | 51.76 | 69.60 | 34.47% | 1.40% | averaged up |
| 08-Oct-2014 | CRH | CRH | 21.30 | 57.00 | 167.61% | 2.10% | spinning off US sub? |
| 14-Sep-2016 | Roche Hldgs | RHHBY | 30.50 | 43.41 | 42.33% | 3.11% | BUY |
| 09-Oct-2017 | Nokia ADR | NOK | 5.92 | 4.56 | -22.97% | 3.90% | BUY |
| 27-Dec-2017 | Antofagasta | ANFGF | 13.34 | 19.59 | 46.85% | 0.00% | BUY |
| 21-Jun-2018 | Johnson-Matthey | JMPLY | 95.89 | 82.64 | -13.82% | 5.00% | BUY |
| 15-Feb-2019 | HangSengBank | HSNGF | 22.75 | 18 | -20.88% | 2.17% | SOLD |
| 05-Mar-2019 | MultipleChoice | MCHOY | 0.51 | 8.35 | 1537.25% | 0.00% | spun off by NPSNY |
| 08-Nov-2019 | Veolia | VEOEY | 24.78 | 26.76 | 8.21% | 2.02% | BUY |
| 14-Jan-2020 | Dr Reddy's | RDY | 41.63 | 61.28 | 47.20% | 0.70% | BUY |
| 01-Jul-2020 | Alimentation Couche-Tard | ANCUF | 33.64 | 30.68 | -8.80% | 0.80% | BEST BUY |
| 21-Dec-2020 | Cosan | CZZ | 18.74 | 17.33 | -8.14% | 5.46% | BUY |
| 02-Dec-2020 | Tower Semiconductor | TSEM | 22.85 | 27.91 | 18.15% | 0.00% | BUY |
| 03-Dec-2020 | Canadian Solar | CSIQ | 41.75 | 54.75 | 23.74% | 5.46% | BUY |
| 07-Jan-2021 | Kirkland Lake | KL | 44.9 | 38.42 | -16.87% | 1.90% | BUY |
| 15-Mar-2018 | Ormat | ORA | 90.28 | 114.16 | 27.89% | 0.40% | 75% sold |
| average gain, yield | 212.36% | 2.06% | |||||
| purchase date | Speculative Portfolio | ticker | Initial | Current | Gain | Yield | |
| For investors willing to take risks | Price | Price | |||||
| 24-Sep-2016 | Teva Pharma ### | TEVA | 12.96 | 11.78 | -9.07% | 0.00% | BUY |
| 06-Feb-2007 | Compugen | CGEN | 2.90 | 12.16 | 319.31% | 0.00% | ½ sold |
| 29-Sep-2017 | Mercado Libre & | MELI | 254.11 | 1,779.51 | 600.29% | 0.00% | 2/3 sold |
| 15-Nov-2017 | AzurePowerGlobal F | AZRE | 7.73 | 37.91 | 390.43% | 0.00% | BUY |
| 01-Jul-2018 | Zymeworks Inc | ZYME | 9.67 | 33.82 | 249.74% | 0.00% | BUY |
| 28-Jan-2021 | Zymeworks Inc | ZYME | 33.38 | 33.82 | 1.32% | ||
| 28-Sep-2018 | Eisei | ESALY | 72.15 | 79.92 | 10.77% | 2.00% | averaged down |
| 28-Sep-2018 | Takeda | TAK | 18.79 | 17.63 | -6.15% | 4.66% | BUY |
| 15-Mar-2019 | Nintendo | NTDOY | 45.65 | 72.27 | 58.31% | 0.14% | half sold |
| 23-Aug-2019 | Energy Fuels | UUUU | 2.09 | 3.80 | 81.82% | 0.00% | BEST BUY |
| 15-Nov-2019 | Nio Inc | NIO | 2.38 | 57.00 | 3425.31% | 0.00% | 2/3 SOLD |
| 05-Dec-2019 | Beigene | BGNE | 170 | 320 | 88.24% | 0.33% | NEW, averaged down |
| 08-Jun-2020 | Ericsson | ERIC | 9.38 | 12.47 | 32.94% | 0.53% | BUY |
| 27-Aug-2020 | Grifols | GRFS | 16.22 | 17.68 | 9.00% | 2.50% | BUY |
| 25-Nov-2020 | Enlivex Theapeutics | ENLV | 8.43 | 11.95 | 41.76% | 0.00% | NEW |
| 11-Dec-2020 | Abcellera | ABCL | 50.66 | 52.83 | 4.28% | 0.00% | NEW |
| 25-Nov-2020 | Aurinia | AUPH | 13.57 | 16.71 | 23.14% | 0.00% | NEW |
| 05-Jan-2021 | Novacure Ltd | NVCR | 161 | 160.96 | -0.02% | 0.00% | new ATM issue |
| 07-Jan-2021 | Trip.com | TCOM | 32.97 | 31.83 | -3.46% | 0.00% | China tourism? |
| average gain, yield | 279.89% | 0.56% | |||||
| (%) = suitable for tax-deferred acct | ### = half sold | &=averaged down | |||||
| G=calculated by Global Investing | Non-PK F=Canadian | ||||||
| Subscribers should open positions in all stocks not marked « sell » in their portfolio |
Performance Table 1/31/21
My latest performance table for subscribers.
Disclaimer: This and other personal blog posts are not reviewed, monitored or endorsed by TalkMarkets. The content is solely the view of the author and TalkMarkets is not responsible for the content of this post in any way. Our curated content which is handpicked by our editorial team may be viewed here.
Comments
Log in or sign up to join the conversation.